$ACHV
ACHIEVE LIFE SCIENCES, INC.

2016 Q1 Form 10-Q Financial Statement

#000156459016019250 Filed on May 12, 2016

View on sec.gov

Income Statement

Concept 2016 Q1 2015 Q4 2015 Q1
Revenue $2.940M $6.024M $1.374M
YoY Change 113.97% 6.62% -88.29%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $2.300M $2.920M $2.700M
YoY Change -14.81% 6.96% -2.17%
% of Gross Profit
Research & Development $65.00K $6.587M $3.673M
YoY Change -98.23% -33.14% -78.27%
% of Gross Profit
Depreciation & Amortization $56.00K $60.00K $46.00K
YoY Change 21.74% 20.0% -16.36%
% of Gross Profit
Operating Expenses $7.372M $6.587M $6.371M
YoY Change 15.71% -33.14% -62.31%
Operating Profit
YoY Change
Interest Expense $50.00K $30.00K $50.00K
YoY Change 0.0% 50.0% 400.0%
% of Operating Profit
Other Income/Expense, Net -$6.000K $1.756M $480.0K
YoY Change -101.25% 78.64% -167.89%
Pretax Income -$3.710M -$1.720M -$4.520M
YoY Change -17.92% -69.72% -47.69%
Income Tax
% Of Pretax Income
Net Earnings -$242.0K -$1.722M -$4.517M
YoY Change -94.64% -69.69% -47.7%
Net Earnings / Revenue -8.23% -28.59% -328.75%
Basic Earnings Per Share
Diluted Earnings Per Share -$371.0M -$172.0M -$452.0M
COMMON SHARES
Basic Shares Outstanding 22.68M
Diluted Shares Outstanding

Balance Sheet

Concept 2016 Q1 2015 Q4 2015 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $46.11M $20.94M $40.40M
YoY Change 14.14% -55.49% 7.45%
Cash & Equivalents $18.91M $67.00K $25.28M
Short-Term Investments $27.20M $20.88M $15.10M
Other Short-Term Assets $233.0K $14.00K $499.0K
YoY Change -53.31% -97.19% -72.28%
Inventory
Prepaid Expenses
Receivables $0.00 $1.559M
Other Receivables $100.0K $0.00
Total Short-Term Assets $47.99M $57.30M $45.51M
YoY Change 5.45% 2.76% -5.49%
LONG-TERM ASSETS
Property, Plant & Equipment $546.0K $600.0K $416.0K
YoY Change 31.25% 133.46% 19.2%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $38.00K $300.0K $272.0K
YoY Change -86.03% 9.89% -74.7%
Total Long-Term Assets $856.0K $902.0K $878.0K
YoY Change -2.51% 70.19% -47.58%
TOTAL ASSETS
Total Short-Term Assets $47.99M $57.30M $45.51M
Total Long-Term Assets $856.0K $902.0K $878.0K
Total Assets $48.84M $58.20M $46.38M
YoY Change 5.3% 3.39% -6.9%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $592.0K $1.300M $988.0K
YoY Change -40.08% 1705.56% 7.04%
Accrued Expenses $10.10M $11.90M $11.40M
YoY Change -11.4% -24.2% -12.58%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $100.0K $100.0K $100.0K
YoY Change 0.0% -50.0% -90.91%
Total Short-Term Liabilities $14.50M $20.66M $16.24M
YoY Change -10.7% -6.99% -3.92%
LONG-TERM LIABILITIES
Long-Term Debt $100.0K $100.0K $100.0K
YoY Change 0.0% -96.97%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $100.0K $100.0K $100.0K
YoY Change 0.0% -96.97%
TOTAL LIABILITIES
Total Short-Term Liabilities $14.50M $20.66M $16.24M
Total Long-Term Liabilities $100.0K $100.0K $100.0K
Total Liabilities $14.60M $20.77M $16.37M
YoY Change -10.79% -6.58% -19.07%
SHAREHOLDERS EQUITY
Retained Earnings -$176.8M -$164.5M
YoY Change 10.54% 15.6%
Common Stock $211.6M $191.9M
YoY Change 10.57% 13.36%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $34.20M $1.840M $30.02M
YoY Change
Total Liabilities & Shareholders Equity $48.80M $58.21M $46.38M
YoY Change 5.21% 3.41% -6.9%

Cashflow Statement

Concept 2016 Q1 2015 Q4 2015 Q1
OPERATING ACTIVITIES
Net Income -$242.0K -$1.722M -$4.517M
YoY Change -94.64% -69.69% -47.7%
Depreciation, Depletion And Amortization $56.00K $60.00K $46.00K
YoY Change 21.74% 20.0% -16.36%
Cash From Operating Activities -$9.090M -$10.68M -$6.440M
YoY Change 41.15% 53.67% 281.07%
INVESTING ACTIVITIES
Capital Expenditures -$70.00K $205.0K
YoY Change 2828.57%
Acquisitions
YoY Change
Other Investing Activities -$6.310M $2.570M $4.080M
YoY Change -254.66% -118.2% -74.03%
Cash From Investing Activities -$6.310M $2.500M $3.880M
YoY Change -262.63% -117.71% -75.29%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 10.00K -50.00K
YoY Change -100.0% -50.0% -266.67%
NET CHANGE
Cash From Operating Activities -9.090M -10.68M -6.440M
Cash From Investing Activities -6.310M 2.500M 3.880M
Cash From Financing Activities 0.000 10.00K -50.00K
Net Change In Cash -15.40M -8.170M -2.610M
YoY Change 490.04% -61.19% -118.59%
FREE CASH FLOW
Cash From Operating Activities -$9.090M -$10.68M -$6.440M
Capital Expenditures -$70.00K $205.0K
Free Cash Flow -$10.61M -$6.645M
YoY Change 52.66% 291.57%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2016Q1 ogxi Lease Termination Liability Current
LeaseTerminationLiabilityCurrent
1250000
CY2016Q1 us-gaap Restructuring Charges
RestructuringCharges
431000
CY2016Q1 us-gaap Operating Expenses
OperatingExpenses
7372000
CY2015Q1 us-gaap Operating Expenses
OperatingExpenses
6371000
CY2015Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
54000
CY2015Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-465000
CY2015Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
13000
CY2015Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
13000
CY2015Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4504000
CY2015Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
22656022
CY2015Q1 us-gaap Depreciation
Depreciation
46000
CY2015Q1 us-gaap Share Based Compensation
ShareBasedCompensation
516000
CY2015Q1 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-42000
CY2015Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-4117000
CY2015Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
842000
CY2015Q1 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
916000
CY2015Q1 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-1849000
CY2015Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-3797000
CY2015Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-602000
CY2015Q1 us-gaap Increase Decrease In Restricted Cash For Operating Activities
IncreaseDecreaseInRestrictedCashForOperatingActivities
-61000
CY2016Q1 us-gaap Assets Current
AssetsCurrent
47985000
CY2016Q1 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
27201000
CY2015Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
20876000
CY2016Q1 us-gaap Other Assets Current
OtherAssetsCurrent
233000
CY2015Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
272000
CY2016Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
546000
CY2016Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
744000
CY2016Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1585000
CY2015Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1987000
CY2016Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
38000
CY2016Q1 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
51000
CY2016Q1 us-gaap Assets
Assets
48841000
CY2016Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
592000
CY2016Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
909000
CY2016Q1 ogxi Accrued Liabilities Clinical Current
AccruedLiabilitiesClinicalCurrent
8450000
CY2016Q1 us-gaap Interest Receivable Current
InterestReceivableCurrent
53000
CY2016Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
2099000
CY2015Q4 us-gaap Other Assets Current
OtherAssetsCurrent
14000
CY2015Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.20
CY2015Q4 us-gaap Assets Current
AssetsCurrent
57298000
CY2016Q1 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
272000
CY2016Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-1516000
CY2016Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-523000
CY2015Q1 us-gaap Net Income Loss
NetIncomeLoss
-4517000
CY2016Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-2941000
CY2015Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-6444000
CY2016Q1 us-gaap Payments For Proceeds From Short Term Investments
PaymentsForProceedsFromShortTermInvestments
24169000
CY2016Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
17859000
CY2015Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
205000
CY2016Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-6310000
CY2015Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
3877000
CY2016Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-15397000
CY2015Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-2619000
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
27897000
CY2015Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
25278000
CY2016Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
438000
CY2016Q1 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
46386000
CY2015Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
1105000
CY2016Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
667000
CY2016Q1 us-gaap Cash
Cash
4350000
CY2016Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
27197000
CY2016Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
6000
CY2016Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
2000
CY2016Q1 ogxi Maximum Maturity Period Of Cash And Cash Equivalents
MaximumMaturityPeriodOfCashAndCashEquivalents
P90D
CY2016Q1 ogxi Maximum Maturity Period Of Short Term Investments
MaximumMaturityPeriodOfShortTermInvestments
P1Y
CY2016Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2016Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2016Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2015Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2016Q1 us-gaap Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
101228
CY2015Q1 us-gaap Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
82410
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1479221
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1513750
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
32205
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2960766
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
8.78
CY2016Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.85
CY2016Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
4.11
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.78
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0152
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00
CY2016Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y3M18D
CY2015Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P0Y
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.7180
CY2016Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
2200000
CY2015Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
1800000
CY2016Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7200000
CY2015Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6900000
CY2016Q1 ogxi Number Of Warrants Exercised
NumberOfWarrantsExercised
0
CY2016Q1 ogxi Expiration Of Operating Lease Agreement
ExpirationOfOperatingLeaseAgreement
2016-09
CY2015Q3 ogxi Expansion Of Rental Space Notice Provided
ExpansionOfRentalSpaceNoticeProvided
2245
CY2016Q1 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
100000
CY2015Q1 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
500000
CY2015Q1 ogxi Additional Contingent Liability Early Termination Of Lease Agreement
AdditionalContingentLiabilityEarlyTerminationOfLeaseAgreement
1300000
CY2016Q1 us-gaap Guarantee Obligations Current Carrying Value
GuaranteeObligationsCurrentCarryingValue
0
CY2016Q1 ogxi Indemnification Expense
IndemnificationExpense
0
CY2016Q1 us-gaap Restructuring And Related Cost Number Of Positions Eliminated
RestructuringAndRelatedCostNumberOfPositionsEliminated
11
CY2016Q1 us-gaap Restructuring And Related Cost Number Of Positions Eliminated Period Percent
RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent
0.27
CY2016Q1 us-gaap Severance Costs1
SeveranceCosts1
400000

Files In Submission

Name View Source Status
0001564590-16-019250-index-headers.html Edgar Link pending
0001564590-16-019250-index.html Edgar Link pending
0001564590-16-019250.txt Edgar Link pending
0001564590-16-019250-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
geypfegtaecb000001.jpg Edgar Link pending
ogxi-10q_20160331.htm Edgar Link pending
ogxi-20160331.xml Edgar Link completed
ogxi-20160331.xsd Edgar Link pending
ogxi-20160331_cal.xml Edgar Link unprocessable
ogxi-20160331_def.xml Edgar Link unprocessable
ogxi-20160331_lab.xml Edgar Link unprocessable
ogxi-20160331_pre.xml Edgar Link unprocessable
ogxi-ex311_6.htm Edgar Link pending
ogxi-ex312_8.htm Edgar Link pending
ogxi-ex321_7.htm Edgar Link pending
ogxi-ex322_9.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending